Back

Evaluation of "stratify and shield" as a policy option for ending the COVID-19 lockdown in the UK

McKeigue, P. M.; Colhoun, H. M.

2020-04-30 epidemiology
10.1101/2020.04.25.20079913 medRxiv
Show abstract

Although population-wide lockdowns have been successful in slowing the COVID-19 epidemic, there is a consensus among disease modellers that keeping the load on critical care services within manageable limits will require an adaptive social distancing strategy, alternating cycles of relaxation and reimposition until a vaccine is available. An alternative strategy that has been tentatively proposed is to shield the elderly and others at high risk of severe disease, while allowing immunity to build up in those at low risk until the entire population is protected. We examine the performance required from a classifier that uses information from medical records to assign risk status for a such a stratify-and-shield policy to be effective in limiting mortality when social distancing is relaxed. We show that under plausible assumptions about the level of immunity required for population-level immunity, the proportion shielded is constrained to be no more than 15% of the population. Under varying assumptions about the infection fatality ratio (from 0.1% to 0.4%) and the performance of the classifier (3 to 4.5 bits of information for discrimination), we calculate the expected number of deaths in the unshielded group. We show that with likely values of the performance of a classifier that uses information from age, sex and medical records, at least 80% of those who would die if unshielded would be allocated to the high-risk shielded group comprising 15% of the population. Although the proportion of deaths that would be prevented by effective shielding does not vary much with the infection fatality ratio, the absolute number of deaths in the unshielded varies from less than 10,000 if the infection fatality rate is 0.1% to more than 50,000 if the infection fatality rate is as high as 0.4%. For projecting the effect of an optimally applied stratify-and-shield policy, studies now under way should help to resolve key uncertainties: the extent to which infection confers immunity, the prevalence of immunity, the infection fatality ratio, and the performance of a classifier constructed using information from medical records. It is time to give serious consideration to a stratify-and-shield policy that could bring the COVID-19 epidemic to an end in a matter of months while restoring economic activity, avoiding overload of critical care services and limiting mortality.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Philosophical Transactions of the Royal Society B: Biological Sciences
72 papers in training set
Top 0.1%
14.9%
2
PLOS ONE
5266 papers in training set
Top 22%
7.8%
3
Journal of Theoretical Biology
162 papers in training set
Top 0.4%
7.2%
4
Royal Society Open Science
214 papers in training set
Top 0.4%
6.2%
5
European Journal of Epidemiology
43 papers in training set
Top 0.1%
5.4%
6
Journal of The Royal Society Interface
235 papers in training set
Top 0.8%
5.1%
7
Epidemics
116 papers in training set
Top 0.5%
4.8%
50% of probability mass above
8
International Journal of Epidemiology
88 papers in training set
Top 0.3%
4.0%
9
PLOS Computational Biology
1863 papers in training set
Top 10%
3.2%
10
Scientific Reports
3612 papers in training set
Top 35%
3.2%
11
BMC Medicine
176 papers in training set
Top 1%
3.1%
12
Communications Medicine
113 papers in training set
Top 1%
2.4%
13
Nature Medicine
125 papers in training set
Top 2%
1.7%
14
Nature Communications
5641 papers in training set
Top 46%
1.7%
15
eLife
5828 papers in training set
Top 52%
1.5%
16
Epidemiology and Infection
89 papers in training set
Top 1%
1.5%
17
Demographic Research
11 papers in training set
Top 0.1%
1.4%
18
Frontiers in Public Health
148 papers in training set
Top 4%
1.3%
19
Mathematical Medicine and Biology: A Journal of the IMA
10 papers in training set
Top 0.2%
1.1%
20
American Journal of Epidemiology
67 papers in training set
Top 1.0%
1.1%
21
BMC Public Health
158 papers in training set
Top 4%
1.0%
22
BMJ Open
601 papers in training set
Top 12%
1.0%
23
BMC Infectious Diseases
133 papers in training set
Top 4%
1.0%
24
Age and Ageing
28 papers in training set
Top 0.4%
1.0%
25
Vaccine
203 papers in training set
Top 2%
0.8%
26
Wellcome Open Research
67 papers in training set
Top 2%
0.6%
27
Statistical Methods in Medical Research
11 papers in training set
Top 0.2%
0.6%
28
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 45%
0.6%